Northwest Natural CFO withholds 763 shares for taxes after RSU vesting
Rhea-AI Filing Summary
Raymond J. Kaszuba III, Senior Vice President and Chief Financial Officer of Northwest Natural Holding Company (NWN), reported the sale of 763 shares of Common Stock on 09/02/2025 at a price of $41.53 per share. The filing states those shares were withheld by the issuer to cover withholding taxes on time-based restricted stock units that vested on September 1, 2025. Following the reported transaction, Kaszuba beneficially owns 7,052 shares, which includes 5,210 restricted stock units granted under the company’s Long Term Incentive Plan that vest in equal installments on September 1, 2026 and 2027. The Form 4 was signed by an attorney-in-fact on 09/04/2025.
Positive
- Transparent disclosure of the sale and the tax-withholding reason
- Substantial continued ownership through 5,210 unvested RSUs that vest in 2026 and 2027
- Transaction aligns with compensation plan mechanics (RSU vesting and withholding)
Negative
- Disposition of shares by the CFO (763 shares) could be viewed negatively by some investors
- Filing does not state whether other planned transactions exist (no Rule 10b5-1 plan box checked)
Insights
TL;DR: Routine tax-withholding sale on vested RSUs; insider still holds substantial equity via unvested RSUs.
The reported disposal of 763 shares reflects a common administrative action where the issuer withholds shares to satisfy tax obligations arising from RSU vesting. The transaction price of $41.53 is disclosed, and post-transaction beneficial ownership is 7,052 shares. Materials indicate 5,210 RSUs remain subject to future vesting in 2026 and 2027, preserving alignment between the CFO and shareholders while providing predictable executive compensation timing.
TL;DR: Disclosure is timely and consistent with compensation plan mechanics; no governance red flags in the filing.
The Form 4 documents a standard withholding event tied to vested time-based RSUs and identifies the long-term incentive schedule. The filing was executed by an attorney-in-fact, which is common practice. There is no indication of opportunistic trading or deviation from the company’s compensation terms in the statement provided.